Global Apoptosis Assays Market Size, Share, Forecast Report, 2020-2027
The global apoptosis assays market is expected to grow significantly over the forecast period. The market held a value of USD 2.99 billion in 2017 and is projected to register a CAGR of 9.4% over the forecast period.
Factors such as increasing R&D expense, growing cell-based research, and growing funding for cancer research are expected to propel the growth of the market. However, required high investment for research activities is likely to hamper the market growth over the forecast period. Recently, the National Institutes of Health (NIH) invested USD 1.65 billion for stem cell research in 2017.
Key players:
Abcom plc, Merck KGaA (Germany), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), GE Healthcare (US), Danaher Corporation (US), Becton, Dickinson and Company (US), Sartorius AG (Germany), Geno Technology (US), GeneCopoeia, Inc. (US), and Promega Corporation (US) are some of the key players in the global apoptosis assays market.
Intended Audience
Apoptosis assays products manufacturers and vendors
Pharmaceutical and biotech companies
Contract research organizations
Various research and consulting firms
Segmentation:
The global apoptosis assays market has been segmented into product, detection technology, application, and end user.
Based on product, the apoptosis assays market is segmented into kits, reagents, instruments, and others. The kits segment accounted for the largest share segment of the market in 2017.
Based on detection technology, the apoptosis assays market is segmented into flow cytometry, fluorescence microscopy, western blot assessment, gel electrophoresis, and others.
Based on application, the apoptosis assays market is segmented into drug discovery and development, stem cell research, and others.
Based on end user, the apoptosis assays market is segmented into pharmaceutical and biological companies, research institutes, and others.
The apoptosis assays market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The apoptosis assays market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European apoptosis assays market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The apoptosis assays market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The apoptosis assays market in the Middle East and Africa has been segmented into the Middle East and Africa.
Regional Market Summary
Geographically, the Americas is anticipated to dominate the global apoptosis assays market owing to well-established players and increasing R&D expenses.
Europe is expected to hold the second largest position in the global apoptosis assays market. The market growth in this region is attributed to the growth in the pharmaceutical and biotech industry.
The apoptosis assays market in the Asia-Pacific region consists of countries, namely, China, Japan, the Republic of Korea, India, Australia, and the Rest of Asia-Pacific. The Asia-Pacific region is expected to be the fastest growing region.
The Middle East and Africa has the least share of the market.
Global Apoptosis Assays Market, by Product
Global Apoptosis Assays Market, by Detection Technology
Global Apoptosis Assays Market, by Application
Global Apoptosis Assays Market, by End User
Global Apoptosis assays Market, by Region
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers